Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors

被引:19
|
作者
Kanamori, Masayuki [1 ]
Kumabe, Toshihiro [1 ]
Sonoda, Yukihiko [1 ]
Nishino, Yoshikazu [2 ]
Watanabe, Mika [3 ]
Tominaga, Teiji [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Miyagi Canc Ctr, Res Inst, Div Epidemiol, Natori, Miyagi 9811293, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808574, Japan
关键词
Oligodendroglioma; Dissemination; Predictive factors; Nestin Ki-67; LOW-GRADE OLIGODENDROGLIOMAS; PHASE-III TRIAL; GLIOBLASTOMA-MULTIFORME; PROGNOSTIC-SIGNIFICANCE; EXPRESSION; GLIOMAS; CHEMOTHERAPY; RADIOTHERAPY; MARKERS; NESTIN;
D O I
10.1007/s11060-008-9762-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The pattern of recurrence and predictive factors for tumor progression, dissemination and survival in oligodendroglial tumors were investigated. 56 consecutive patients with oligodendroglial tumors were retrospectively analyzed to determine the predictive significance of various factors, including World Health Organization grade, loss of chromosomes 1p and 19q, and immunohistochemical features of TP53, O-6-methylguanine-deoxyribonucleic-acid-methyltransferase, CD44H, nestin, and Ki-67. Eleven patients developed dissemination, and had significantly shorter post-progression survival compared to ten patients with local recurrence. Univariate analysis showed that retention of chromosome 1p or 19q, Ki-67 labeling index a parts per thousand yen 25%, diffuse expression of nestin, and p53 labeling index a parts per thousand yen 10% were unfavorable factors for overall, progression-free, and dissemination-free survival. Multivariate analysis showed that Ki-67 labeling index a parts per thousand yen 25% and diffuse expression of nestin were significant for dissemination-free survival. In conclusion, post-progression survival shows significant differences between patients with local and disseminated recurrence. Ki-67 labeling index and nestin expression pattern are useful markers to predict dissemination.
引用
收藏
页码:219 / 228
页数:10
相关论文
共 50 条
  • [1] Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors
    Masayuki Kanamori
    Toshihiro Kumabe
    Yukihiko Sonoda
    Yoshikazu Nishino
    Mika Watanabe
    Teiji Tominaga
    Journal of Neuro-Oncology, 2009, 93 : 219 - 228
  • [2] Factors impacting progression-free survival (PFS) as a predictor of overall survival (OS)
    Stewart, David J.
    Bosse, Dominick
    Hilton, John Frederick
    Goss, Glenwood D.
    Fung-Kee-Fung, Michael
    Jonker, Derek J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Prognostic Factors for Progression-free Survival and Overall Survival Αfter Recurrence of Glioblastoma
    Zemskova, Oksana
    Yu, Nathan y.
    Leppert, Jan
    Rades, Dirk
    ANTICANCER RESEARCH, 2024, 44 (07) : 3059 - 3066
  • [4] Prognostic factors for progression-free and overall survival in malignant pleural mesothelioma
    Guzman-Casta, Jordi
    Carrasco-CaraChards, Sonia
    Guzman-Huesca, Jorge
    Sanchez-Rios, Carla Paola
    Riera-Sala, Rodrigo
    Martinez-Herrera, Jose Fabian
    Pena-Mirabal, Erika Sagrario
    Bonilla-Molina, Diana
    Alatorre-Alexander, Jorge Arturo
    Martinez-Barrera, Luis Manuel
    Rodriguez-Cid, Jeronimo Rafael
    THORACIC CANCER, 2021, 12 (07) : 1014 - 1022
  • [5] Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer
    Fakhry, Carole
    Zhang, Qiang
    Nguyen-Tan, Phuc Felix
    Rosenthal, David I.
    Weber, Randal S.
    Lambert, Louise
    Trotti, Andy M., III
    Barrett, William L.
    Thorstad, Wade L.
    Jones, Christopher U.
    Yom, Sue S.
    Wong, Stuart J.
    Ridge, John A.
    Rao, Shyam S. D.
    Bonner, James A.
    Vigneault, Eric
    Raben, David
    Kudrimoti, Mahesh R.
    Harris, Jonathan
    Le, Quynh-Thu
    Gillison, Maura L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (36) : 4057 - +
  • [6] Concordance index: Surrogacy of progression-free survival for overall survival
    Fan, Yiwei
    Yin, Guosheng
    CONTEMPORARY CLINICAL TRIALS, 2021, 104
  • [7] Progression-free survival (PFS) as a surrogate for overall survival (OS)
    Stewart, David J.
    Bosse, Dominick
    Hilton, John
    Goss, Glenwood
    Fung-Kee-Fung, Michael
    Jonker, Derek
    CANCER RESEARCH, 2018, 78 (13)
  • [8] Prognostic factors for progression-free and overall survival in advanced biliary tract cancer
    Bridgewater, J.
    Lopes, A.
    Wasan, H.
    Malka, D.
    Jensen, L.
    Okusaka, T.
    Knox, J.
    Wagner, D.
    Cunningham, D.
    Shannon, J.
    Goldstein, D.
    Moehler, M.
    Bekaii-Saab, T.
    McNamara, M. G.
    Valle, J. W.
    ANNALS OF ONCOLOGY, 2016, 27 (01) : 134 - 140
  • [9] EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
    Bramuzzo, I.
    Gerussi, A.
    Maier, S.
    Bianco, C.
    Romanin, A.
    Pasini, C. Laghi
    Barghini, V.
    Scata, L.
    Donnini, D.
    Uzzau, A.
    Vit, A.
    Sechi, L. A.
    Soardo, G.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E217 - E217
  • [10] Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors
    Michiels, Stefan
    Saad, Everardo D.
    Buyse, Marc
    DRUGS, 2017, 77 (07) : 713 - 719